Across Canada, healthcare providers are closely modifying their approaches to BZD prescribing following the release of updated guidelines. These recommendations aim to minimize the risks associated with long-term use and reliance, emphasizing the critical need of detailed patient evaluations and considering different therapy options. The emphasis i